Amy L. Richmond

Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients

James H. Finke, Brian I. Rini, Joanna Ireland et al. · Clinical Cancer Research · 2008 · 485 citations

Medicine, Oncology, Pharmacology +17

ATG16L1 and NOD2 Interact in an Autophagy-Dependent Antibacterial Pathway Implicated in Crohn's Disease Pathogenesis

Craig R. Homer, Amy L. Richmond, Nancy A. Rebert et al. · Gastroenterology · 2010 · 364 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Glioblastomas Induce T-Lymphocyte Death by Two Distinct Pathways Involving Gangliosides and CD70

Ali Chahlavi, Patricia Rayman, Amy L. Richmond et al. · Cancer Research · 2005 · 142 citations

Life Sciences, Cell Biology, Oncology +17

Expression of EphA2 is Prognostic of Disease-Free Interval and Overall Survival in Surgically Treated Patients with Renal Cell Carcinoma

Christopher J. Herrem, Tomohide Tatsumi, Kathleen S. Olson et al. · Clinical Cancer Research · 2005 · 99 citations · Full text

Medicine, Cancer Biology, Oncology +15

GM2 Expression in Renal Cell Carcinoma: Potential Role in Tumor-Induced T-Cell Dysfunction

Kaushik Biswas, Amy L. Richmond, Patricia Rayman et al. · Cancer Research · 2006 · 88 citations

Life Sciences, Immunology, Oncology +17